FDA Approved: PYRIDOSTIGMINE BROMIDE — Supplemental Application (Oceanside Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for pyridostigmine bromide submitted by Oceanside Pharmaceuticals, resulting in updated labeling under NDA 11665.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• Mestinon (pyridostigmine bromide)
• Pyridostigmine bromide (Pyridostigmine bromide)

Snippet

SUPPL AP for PYRIDOSTIGMINE BROMIDE (PYRIDOSTIGMINE BROMIDE)